story of the week
Metastatic Site Patterns by Intrinsic Subtype and HER2DX Risk Scores in Patients With Early-Stage HER2-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer
J. Natl. Cancer Inst 2023 Sep 07;[EPub Ahead of Print], MV Dieci, PP Conte, PG Bisagni, S Bartolini, A Frassoldati, D Generali, F Piacentini, G Griguolo, E Tagliafico, F Brasó Maristany, N Chic, L Paré, F Miglietta, R Vicini, R D'Amico, S Balduzzi, A Prat, V GuarneriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.